Reply to Harsanyi et al. Comment on "Hasan et al. Clinico-Pathological Features and Immunohistochemical Comparison of p16, p53, and Ki-67 Expression in Muscle-Invasive and Non-Muscle-Invasive Conventional Urothelial Bladder Carcinoma. Here, TP53 is linked to bladder transitional cell carcinoma.